N/A
Completed N=590
Fatigue Management Programs for People With MS
Source: ClinicalTrials.gov NCT03550170 ↗Enrolled (actual)
590
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcomePrimary: Change From Baseline in Fatigue Levels — 50.98; 56.88; 57.87 score on a scale
Summary
This is a multi-site randomized clinical trial comparing 3 modes of delivering the Managing Fatigue course for reducing fatigue in individuals with multiple sclerosis (MS). The primary hypothesis is that the teleconference and internet versions of the course will be noninferior to the one-on-one, in person version in terms of the primary outcome of fatigue and secondary outcome of quality of life.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Fatigue Levels |
50.98; 56.88; 57.87 | — |
| SECONDARY Change From Baseline in Health-related Quality of Life: Psychological Composite |
40.93; 38.66; 37.77 | 0.10 |
Eligibility Criteria
Inclusion Criteria
- Self-report diagnosis of MS
- Age ≥ 18 years
- Fatigue Severity Scale score ≥ 4
- Ability to speak English
Exclusion Criteria
- Individual must be capable of providing consent (Assessed with questionnaire)
- Unable to access the internet or unable to travel to in-person sessions
Data sourced from ClinicalTrials.gov (NCT03550170). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.